AIM
KDNY

Acrospire Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Acrospire Investment Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,940
Closed -$110K – 2215
2016
Q2 		$110K Buy
1,940
+420
+28% +$23.8K 0.08% 371
2016
Q1 		$97K Buy
+1,520
New +$97K 0.07% 342